MY143213A - Ifnar2 mutants, their production and use - Google Patents

Ifnar2 mutants, their production and use

Info

Publication number
MY143213A
MY143213A MYPI20042431A MY143213A MY 143213 A MY143213 A MY 143213A MY PI20042431 A MYPI20042431 A MY PI20042431A MY 143213 A MY143213 A MY 143213A
Authority
MY
Malaysia
Prior art keywords
production
ifnar2
mutants
ifn
mutant
Prior art date
Application number
Inventor
Gideon Schreiber
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to MYPI20042431 priority Critical patent/MY143213A/en
Publication of MY143213A publication Critical patent/MY143213A/en

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

THE PRESENT INVENTION RELATES TO MUTANT POLYPEPTIDES OF THE BETA CHAIN OF THE TYPE I IFN RECEPTOR (MIFNAR2 MUTANT) WITH ENHANCED AFFINITY FOR INTERFERON-ß AS COMPARED TO THE WILD TYPE PROTEIN FOR PROLONGING THE EFFECT OF IFN-ß IN VIVO.
MYPI20042431 2004-06-22 2004-06-22 Ifnar2 mutants, their production and use MY143213A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20042431 MY143213A (en) 2004-06-22 2004-06-22 Ifnar2 mutants, their production and use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20042431 MY143213A (en) 2004-06-22 2004-06-22 Ifnar2 mutants, their production and use

Publications (1)

Publication Number Publication Date
MY143213A true MY143213A (en) 2011-03-31

Family

ID=45020752

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20042431 MY143213A (en) 2004-06-22 2004-06-22 Ifnar2 mutants, their production and use

Country Status (1)

Country Link
MY (1) MY143213A (en)

Similar Documents

Publication Publication Date Title
HK1084151A1 (en) Interleukin-18 mutants, their production and use
SG165353A1 (en) Improved human interferon molecules and their uses
HK1082200A1 (en) Compositions and methods for the therapy of inflammatory bowel disease
SG161247A1 (en) Variant forms of urate oxidase and use thereof
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
HK1151553A1 (en) Mesenchymal stem cells expressing tnf-receptor
HK1074670A1 (en) Sets of digital antibodies directed against short epitopes, and methods using same
AU303031S (en) Seating unit with arm rests
SG165339A1 (en) Incorporation of non-naturally encoded amino acids into proteins
WO2007030761A3 (en) Acyclic 1,4-diamines and uses thereof
TW200517107A (en) Novel formulation
EP1978994A4 (en) Bmp-7 variant compositions, methods and uses
WO2004081043A3 (en) Baff mutants with at least one amino acid substitution and methods of their production
MXPA04006383A (en) Ifnar2 mutants, their production and use.
MY143213A (en) Ifnar2 mutants, their production and use
MX2008008322A (en) Fsh mutants.
WO2007011765A3 (en) Methods of identifying and treating individuals exhibiting mutant src kinase polypeptides
WO2006069765A3 (en) Secreted polypeptide species involved in multiple sclerosis
AU2003259750A8 (en) Methods and compositions for targeting secretory lysosomes
RS20060023A (en) Use of soluble cd164 in inflammatory and/or autoimmune disorders
MY142798A (en) Methods for preventing glyconoylation of proteins
WO2003095484A3 (en) Polypeptides increasing p53 expression
ZA200705973B (en) N protein mutants of porcine reproductive and respiratory syndrome virus
AU300552S (en) Design 2: chair
BR8201310U (en) Metal structure upholstery